iBio, Inc. (IBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

0 900K 1.8M 2.7M Q4 '21: 2.4M Q1 '22: 2M Q2 '22: 1.3M Q3 '22: 2.4M Q4 '22: 1.9M Q1 '23: 1.8M Q2 '23: 1.8M Q3 '23: 0 Q4 '23: 0 Q1 '24: 50K Q2 '24: 50K Q3 '24: 50K Q4 '24: 225K Q1 '25: 175K Q2 '25: 375K Q3 '25: 375K Q4 '25: 400K Q1 '26: 500K Q2 '26: 300K Q3 '26: 300K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit TTM

0 900K 1.8M 2.7M Q2 '21: 1.6M Q3 '21: 1.9M Q4 '21: 1.4M Q1 '22: 1.2M Q2 '22: 802K Q3 '22: 2.4M Q4 '22: 2.2M Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '21: -31.1M Q1 '22: -29.4M Q2 '22: -29.1M Q3 '22: -28.7M Q4 '22: -29.7M Q1 '23: -32.1M Q2 '23: -35.5M Q3 '23: -34.8M Q4 '23: -29.3M Q1 '24: -26.8M Q2 '24: -20.7M Q3 '24: -18.2M Q4 '24: -16.6M Q1 '25: -15.6M Q2 '25: -15.6M Q3 '25: -16.8M Q4 '25: -18.6M Q1 '26: -20.4M Q2 '26: -25.5M Q3 '26: -29M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q1 '22: -24.6M Q2 '22: -28.4M Q3 '22: -33.1M Q4 '22: -50.3M Q1 '23: -59.5M Q2 '23: -81.1M Q3 '23: -76M Q4 '23: -65M Q1 '24: -52.6M Q2 '24: -27.3M Q3 '24: -23.2M Q4 '24: -24.9M Q1 '25: -23.1M Q2 '25: -19.3M Q3 '25: -21M Q4 '25: -18.4M Q1 '26: -20.1M Q2 '26: -24.7M Q3 '26: -27.6M Q4 '26: -32.8M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue TTM

0 400K 800K 1.2M Q2 '21: 703K Q3 '21: 1.1M Q4 '21: 998K Q1 '22: 931K Q2 '22: 833K Q3 '22: 388K Q4 '22: 216K Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q4 '21: -30.1M Q1 '22: -32.3M Q2 '22: -34.6M Q3 '22: -33.2M Q4 '22: -37.5M Q1 '23: -42.1M Q2 '23: -39M Q3 '23: -37M Q4 '23: -30.4M Q1 '24: -21.8M Q2 '24: -18.9M Q3 '24: -18.7M Q4 '24: -18.6M Q1 '25: -16.9M Q2 '25: -16.1M Q3 '25: -15.5M Q4 '25: -15.3M Q1 '26: -17.3M Q2 '26: -18.6M Q3 '26: -21.6M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '20: -14.3M Q4 '20: -14.4M Q1 '21: -19.6M Q2 '21: -25.4M Q3 '21: -29.9M Q4 '21: -35M Q1 '22: -38M Q2 '22: -41.4M Q3 '22: -39.6M Q4 '22: -44.8M Q1 '23: -50.8M Q2 '23: -48.5M Q3 '23: -45.6M Q4 '23: -36.2M Q2 '25: -16.3M Q3 '25: -15.8M Q4 '25: -15.3M Q1 '26: -17.3M Q2 '26: -19.2M Q3 '26: -22.2M Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '14: 60.6M Q2 '14: 64M Q1 '15: 65.9M Q2 '15: 71M Q3 '21: 215.5M Q1 '22: 8.7M Q2 '22: 8.7M Q3 '22: 8.7M Q1 '23: 8.8M Q2 '23: 490K Q3 '23: 659K Q1 '24: 1.2M Q2 '24: 1.9M Q3 '24: 3.7M Q1 '25: 8.6M Q2 '25: 9.1M Q3 '25: 9.9M Q1 '26: 53M Q2 '26: 99.1M Q3 '26: 119.6M Q2 '14 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q4 '21: -3.01 Q1 '22: -5.36 Q2 '22: -6.69 Q3 '22: -8.07 Q4 '22: -7.15 Q1 '23: -6.80 Q2 '23: -73.86 Q3 '23: -83.51 Q4 '23: -76.46 Q1 '24: -79.21 Q2 '24: -15.20 Q3 '24: -4.98 Q4 '24: -6.50 Q1 '25: -2.16 Q2 '25: 1.78 Q3 '25: 2.14 Q4 '25: -1.74 Q1 '26: -1.39 Q2 '26: -1.00 Q3 '26: -0.57 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.